News

The goal of the program is to evaluate DelSite’s parenteral technologies. DelSite has also agreed to provide GelSite polymer and technical information concerning the optimal solubilization and mixing

Helicos’s proprietary True Single Molecule Sequencing (tSMS) technology directly sequences single molecules of DNA or RNA, an advance that enables unparalleled accuracy, simplicity and scale in genomic experimentation.

In Phase I clinical trials, LX6171 was generally well tolerated at all dose levels and showed good systemic exposure with no significant adverse events or cognitive impairment observed.

Acceptance of the filing means that FDA has made a threshold determination that the new drug application (NDA) is sufficiently complete to permit a substantive review. Pursuant to

Under the terms of the agreement, American Oriental Bioengineering makes an equity investment of $18 million in exchange for 30 million shares of newly-issued China Aoxing common stock,

For Q1 2008, operational growth was 2.6% and currency contributed 5.1%. Domestic sales were up 2.8%, while international sales increased 13.7%, reflecting operational growth of 2.4% and a

The alliance will focus on providing glycotherapeutic products and services for research through to process scale-up and commercialization by way of an exclusive referral and co-marketing arrangement. Commonwealth

The Phase IIb dose-ranging clinical trial is a randomized, examiner-blinded, parallel design trial comparing three different doses of PAC-113 to Nystatin, consisting of two week treatment phase and

Under the arrangement, Boston Scientific will gain access to Surgi- Vision’s development capabilities and will obtain a license to Surgi-Vision’s intellectual property for potential use in its implantable